Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients
Clinical trial NCT02477865 · UNKNOWN
Trial details
- NCT number
- NCT02477865
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-23
- Primary completion
- 2016-05-15
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.